These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2877486)

  • 21. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
    Bouckaert F; Herman G; Peuskens J
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
    Bressan RA; Jones HM; Pilowsky LS
    J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of tardive syndromes with clozapine: a case series.
    Grover S; Hazari N; Kate N; Chakraborty K; Sharma A; Singh D; Gupta J; Lahariya S
    Asian J Psychiatr; 2014 Apr; 8():111-4. PubMed ID: 24655641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress of treatment for antipsychotics induced tardive dyskinesia and its integrative medical therapy].
    Su JM; Cao YY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Nov; 30(11):1128-9. PubMed ID: 21275158
    [No Abstract]   [Full Text] [Related]  

  • 26. [Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia].
    Kozian R; Friederich M
    Psychiatr Prax; 2007 Jul; 34(5):253-4. PubMed ID: 17597439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
    Lykouras L; Rizos E; Gournellis R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1535-6. PubMed ID: 17614184
    [No Abstract]   [Full Text] [Related]  

  • 28. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baclofen in the treatment of tardive dyskinesia.
    Nair NP; Yassa R; Ruiz-Navarro J; Schwartz G
    Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of tardive dyskinesia and mania with RBC lithium determinations.
    Ereshefsky L; Rubin TN; Friedman S
    Am J Psychiatry; 1979 Apr; 136(4B):570-3. PubMed ID: 34329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.
    Richardson MA; Bevans ML; Read LL; Chao HM; Clelland JD; Suckow RF; Maher TJ; Citrome L
    Am J Psychiatry; 2003 Jun; 160(6):1117-24. PubMed ID: 12777270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of tiapride in persistent tardive dyskinesia following treatment with neuroleptics].
    Rust M
    MMW Munch Med Wochenschr; 1983 May; 125(21):461-2. PubMed ID: 6135985
    [No Abstract]   [Full Text] [Related]  

  • 36. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia and antiparkinsonian medication.
    Chouinard G; De Montigny C; Annable L
    Am J Psychiatry; 1979 Feb; 136(2):228-9. PubMed ID: 32778
    [No Abstract]   [Full Text] [Related]  

  • 38. Tardive dyskinesia in patients treated with antipsychotics in chronic wards in Taipei.
    Lin HN; Chen CY
    Taiwan Yi Xue Hui Za Zhi; 1980 Mar; 79(3):332-7. PubMed ID: 6104687
    [No Abstract]   [Full Text] [Related]  

  • 39. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive dyskinesia.
    Lancet; 1979 Sep; 2(8140):447-8. PubMed ID: 89504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.